Waypoint Wealth Counsel Abb Vie Inc. Transaction History
Waypoint Wealth Counsel
- $131 Billion
- Q2 2024
A detailed history of Waypoint Wealth Counsel transactions in Abb Vie Inc. stock. As of the latest transaction made, Waypoint Wealth Counsel holds 3,354 shares of ABBV stock, worth $580,745. This represents 0.44% of its overall portfolio holdings.
Number of Shares
3,354
Previous 3,399
1.32%
Holding current value
$580,745
Previous $619 Million
7.04%
% of portfolio
0.44%
Previous 0.48%
Shares
7 transactions
Others Institutions Holding ABBV
# of Institutions
3,649Shares Held
1.24BCall Options Held
15.5MPut Options Held
11.5M-
Vanguard Group Inc Valley Forge, PA170MShares$29.5 Billion0.62% of portfolio
-
Black Rock Inc. New York, NY143MShares$24.8 Billion0.61% of portfolio
-
State Street Corp Boston, MA78MShares$13.5 Billion0.64% of portfolio
-
Jpmorgan Chase & CO New York, NY51.3MShares$8.88 Billion0.85% of portfolio
-
Capital International Investors Los Angeles, CA48.1MShares$8.33 Billion1.81% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $306B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...